Trial Profile
A Phase I/II Trial of Combined Chemotherapy with S-1 and Irinotecan in Patients with Recurrent Cervical Cancer.
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 28 Nov 2018
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Irinotecan (Primary)
- Indications Cervical cancer
- Focus Adverse reactions; Therapeutic Use
- 22 Nov 2018 Status changed from recruiting to discontinued.
- 23 Jan 2015 New trial record